Effective methylation triage of HPV positive women with abnormal cytology in a middle‐income country
Authors:
- Adam R. BrentnallABAdam R. Brentnall
- Kate CuschieriKCKate Cuschieri
- Jack CuzickJCJack Cuzick
- Attila T. LorinczALAttila T. Lorincz
- ASC‐US‐COL Trial GroupAGASC‐US‐COL Trial Group
Open Access
- 2 October 2020
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 148 (6) , 1383-1393
Abstract
The S5‐methylation test, an alternative to cytology and HPV16/18 genotyping to triage high‐risk HPV‐positive (hrHPV+) women, has not been widely validated in low‐middle‐income countries (LMICs). We compared S5 to HPV16/18 and cytology to detect cervical intraepithelial neoplasia Grade 2 or worse (CIN2+) and CIN3+ in hrHPV+ women selected from a randomized pragmatic trial of 2661 Colombian women with an earlier‐borderline abnormal cytology. We included all hrHPV+ CIN2 and CIN3+ cases (n = 183) age matched to 183 P < .05) or cytology (P < .0001). At this cut‐point S5 specificity (76%, 95% CI 69.8‐82.1 for P = .0062) and similar to cytology (75.57%, 95% CI 69.34‐81.79, P = 1). HPV16/18 plus cytology sensitivity was similar to S5 for CIN3+, however, false‐positive rate was higher (50.27% vs. 24.04%). High sensitivity is crucial in LMICs, S5‐methylation exceeded HPV16/18 or cytology sensitivity with comparable specificity for CIN2+ and CIN3+ in hrHPV‐positive Colombian women. Furthermore, S5 triage had comparable sensitivity and significantly fewer false positives than cytology and HPV16/18 combination.Keywords
Funding Information
- Cancer Research UK (C569/A10404)
- Departamento Administrativo de Ciencia, Tecnologia e Innovacion (111545921657, 111556933797)
- Universidad de Antioquia (Estrategia de Sostenibilidad 2013–2014)
This publication has 28 references indexed in Scilit:
- Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high‐risk HPV‐positive women of a gynecologic outpatient population (COMETH study)International Journal of Cancer, 2015
- Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive womenGynecologic Oncology, 2014
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trialsThe Lancet, 2014
- Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical CancerCancer Epidemiology, Biomarkers & Prevention, 2012
- Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trialThe Lancet, 2011
- Evaluation of 14 triage strategies for HPV DNA‐positive women in population‐based cervical screeningInternational Journal of Cancer, 2011
- Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panelHuman Mutation, 2009
- Human papillomavirus and cervical cancerThe Lancet, 2007
- Accuracy of the Papanicolaou Test in Screening for and Follow-up of Cervical Cytologic AbnormalitiesAnnals of Internal Medicine, 2000
- Validity and Reproducibility of Cytologic Diagnosis in a Sample of Cervical Cancer Screening Centers in MexicoActa Cytologica, 1997